Neutrophil extracellular traps: a catalyst for atherosclerosis
- PMID: 38401035
- DOI: 10.1007/s11010-024-04931-3
Neutrophil extracellular traps: a catalyst for atherosclerosis
Abstract
Neutrophil extracellular traps (NETs) are network-like structures released by activated neutrophils. They consist mainly of double-stranded DNA, histones, and neutrophil granule proteins. Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC). Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis. Furthermore, experimental findings have shed light on the molecular mechanisms by which NETs contribute to atherogenesis. NETs play a significant role in the formation of atherosclerotic plaques. This review focuses on recent advancements in the understanding of the relationship between NETs and atherosclerosis. It explores various aspects, including the formation of NETs in atherosclerosis, clinical trials investigating NET-induced atherosclerosis, the mechanisms by which NETs promote atherogenesis, and the translational implications of NETs. Ultimately, we aim to propose new research directions for the diagnosis and treatment of atherosclerosis.
Keywords: Atherosclerosis; Inflammation; Neutrophil extracellular traps; Neutrophils.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis.Atherosclerosis. 2019 Sep;288:9-16. doi: 10.1016/j.atherosclerosis.2019.06.919. Epub 2019 Jun 29. Atherosclerosis. 2019. PMID: 31280097 Review.
-
Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis.Circ Res. 2017 Feb 17;120(4):736-743. doi: 10.1161/CIRCRESAHA.116.309692. Circ Res. 2017. PMID: 28209798 Review.
-
Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.Circ Res. 2020 Apr 24;126(9):1228-1241. doi: 10.1161/CIRCRESAHA.120.315931. Epub 2020 Apr 23. Circ Res. 2020. PMID: 32324499 Free PMC article. Review.
-
Neutrophil Extracellular Traps in Atherosclerosis: Research Progress.Int J Mol Sci. 2025 Mar 6;26(5):2336. doi: 10.3390/ijms26052336. Int J Mol Sci. 2025. PMID: 40076955 Free PMC article. Review.
-
Neutrophil extracellular traps contributing to atherosclerosis: From pathophysiology to clinical implications.Exp Biol Med (Maywood). 2023 Aug;248(15):1302-1312. doi: 10.1177/15353702231184217. Epub 2023 Jul 15. Exp Biol Med (Maywood). 2023. PMID: 37452714 Free PMC article. Review.
Cited by
-
Nano Delivery System for Atherosclerosis.J Funct Biomater. 2024 Dec 24;16(1):2. doi: 10.3390/jfb16010002. J Funct Biomater. 2024. PMID: 39852558 Free PMC article. Review.
-
Multi-Omics Analysis Combined with Machine Learning Identified FABP4 in Smooth Muscle Cells as a Pathogenic Factor in Atherosclerosis.J Inflamm Res. 2025 Jul 26;18:10029-10049. doi: 10.2147/JIR.S519114. eCollection 2025. J Inflamm Res. 2025. PMID: 40740974 Free PMC article.
-
Hair Calcium Levels in Relation to Coronary Artery Disease Severity and Systemic Inflammation Markers: A Pilot Study.J Clin Med. 2025 Jun 26;14(13):4537. doi: 10.3390/jcm14134537. J Clin Med. 2025. PMID: 40648911 Free PMC article.
-
The web of intrigue: unraveling the role of NETosis within the gut-microbiome-immune-heart axis in acute myocardial infarction and heart failure.Cardiovasc Endocrinol Metab. 2024 Aug 8;13(3):e0309. doi: 10.1097/XCE.0000000000000309. eCollection 2024 Sep. Cardiovasc Endocrinol Metab. 2024. PMID: 39130369 Free PMC article. Review.
-
Lipoprotein(a)'s Role in Atherosclerosis and Aortic Stenosis: A Contemporary Literature Review.Cureus. 2024 Jun 23;16(6):e62984. doi: 10.7759/cureus.62984. eCollection 2024 Jun. Cureus. 2024. PMID: 39044888 Free PMC article. Review.
References
-
- Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS et al (2019) Atherosclerosis. Nat Rev Dis Primers 5:56. https://doi.org/10.1038/s41572-019-0106-z - DOI - PubMed
-
- Libby P (2021) The changing landscape of atherosclerosis. Nature 592:524–533. https://doi.org/10.1038/s41586-021-03392-8 - DOI - PubMed
-
- Wolf D, Ley K (2019) Immunity and Inflammation in Atherosclerosis. Circ Res 124:315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591 - DOI - PubMed - PMC
-
- Soehnlein O, Libby P (2021) Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov 20:589–610. https://doi.org/10.1038/s41573-021-00198-1 - DOI - PubMed - PMC
-
- Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P et al (2021) The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J 42:896–903. https://doi.org/10.1093/eurheartj/ehaa1034 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical